Emicizumab‑kxwh bulk supplier for pharma manufacturers

Emicizumab‑Kxwh Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL

Reference Brands: Hemlibra (USA/EU)

Category: Plasma Products

Emicizumab‑kxwh is available in Injection and strengths such as 30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Emicizumab‑kxwh is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Emicizumab‑kxwh can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

What is Emicizumab-kxwh made from? Emicizumab-kxwh is made from a recombinant humanized monoclonal antibody. It is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells.

What is trade name of Emicizumab-kxwh? The trade name of Emicizumab-kxwh is Hemlibra.

What company makes Emicizumab-kxwh? Emicizumab-kxwh is manufactured by Genentech, a member of the Roche Group.

What is generic name of Emicizumab-kxwh? The generic name of this product is Emicizumab-kxwh.

What is brand name of Emicizumab-kxwh? The brand name is Hemlibra.

Where is Emicizumab-kxwh manufactured? Emicizumab-kxwh (Hemlibra) is manufactured by Genentech, Inc., South San Francisco, California, USA, and also produced at Roche facilities in Japan and Switzerland.

Yes, Emicizumab‑kxwh is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Emicizumab‑kxwh is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Marstacimab‑Hncq

Strength:
150 mg/mL

Form: injection (prefilled syringe)

Reference Brands: Hympavzi (USA)

View Details
Concizumab-Mtci

Strength:
60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL

Form: Prefilled autoinjector

Reference Brands: Alhemo (USA/EU)

View Details
Fresh Frozen Plasma (Ffp) Powder For Reconstitution Or Liquid

Strength:
available in 200-250 mL units

Form: liquid units or lyophilized (freeze-dried) powder

Reference Brands: No specific brands

View Details
Plasma Protein Fraction (Ppf) Powder

Strength:
50 mL, 250 mL, or 500 mL

Form: Lyophilized Powder or Liquid

Reference Brands: Plasmanate (US), Octaplas LG, Biotest Plasma (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.